Principal Investigator
Lindsay Karr Thornton
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20231042
Clinical Trial Summary
UPCC 04219 Phase 2 Study of Capecitabine-Temozolomide(CapTem) with yttrium-90 Radioembolization in the Treatment of Patients with Unresectable Metastatic Grade 2 Neuroendocrine Tumors
Phase
Phase II
Funding Agency/Sponsor
Institutional
Disease
Pancreatic, Liver, and Related Cancers
Contact Information
Phone Number
305-243-2647